HRAS Antikörper
Kurzübersicht für HRAS Antikörper (ABIN5700942)
Target
Alle HRAS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Immunogen
- v-Ha-ras Harvey rat sarcoma viral oncogene homolog
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
HEK-293 cells were subjected to SDS PAGE followed by western blot with FNab04008( HRAS-Specific Antibody) at dilution of 1:300
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Haltbarkeit
- 12 months
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Andere Bezeichnung
- HRAS
-
Molekulargewicht
- 21 kDa
-
Pathways
- p53 Signalweg, MAPK Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Hepatitis C, Autophagie, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Target
-